Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENA CAR-T in r/r B-cell NHL
NCT06014073Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ET-901 in B-cell non-Hodgkin lymphoma, sponsored by Chinese PLA General Hospital. Started Sep 2023; status: recruiting.
02
Drugs
ET-901
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT06014073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014073.